Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioRestorative Therapies Inc BRTX

Healthcare Biotechnology
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more

Recent & Breaking News (NDAQ:BRTX)

BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program

GlobeNewswire May 7, 2018

BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development

GlobeNewswire January 22, 2018

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan

GlobeNewswire October 17, 2017

BioRestorative Therapies Announces Published Study of Licensed Technology to Treat Lumbar Degenerative Disc Disease

GlobeNewswire October 5, 2017

BioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference

GlobeNewswire June 14, 2017

BioRestorative Therapies Receives Notice of Acceptance for Key Metabolic Patent in Australia

GlobeNewswire April 20, 2017

BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease

GlobeNewswire February 8, 2017

BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease

GlobeNewswire January 9, 2017

BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease

GlobeNewswire September 12, 2016

BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course

GlobeNewswire July 13, 2016

BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain

GlobeNewswire June 28, 2016

BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference

GlobeNewswire May 31, 2016

BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders

GlobeNewswire May 23, 2016

BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US

GlobeNewswire February 23, 2016

BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product

GlobeNewswire February 9, 2016

BioRestorative Therapies Provides Company Updates With Shareholder Letter

GlobeNewswire December 21, 2015

BioRestorative Therapies Appoints John M. Desmarais, J.D. to Its Board of Directors

GlobeNewswire December 2, 2015

BioRestorative Therapies Granted Key Metabolic Patent

GlobeNewswire November 19, 2015

BioRestorative Therapies Announces Patent Granted for Its Licensed Curved Needle Device

GlobeNewswire November 3, 2015

BioRestorative Therapies Announces Research Collaboration With University of Pennsylvania

GlobeNewswire September 15, 2015